Organoid-based neutralization assays reveal a distinctive profile of SARS-CoV-2 antibodies and recapitulate the real-world efficacy

Journal:
Proceedings of the National Academy of Sciences of the United States of America
Published:
DOI:
10.1073/pnas.2509616122
Affiliations:
10
Authors:
26
Go to article
Institutions Authors Share
Li Ka Shing Faculty of Medicine, HKU, China
13.700000
13.700000
 0.53
Centre for Virology, Vaccinology and Therapeutics, China
3.700000
 0.14
BiomOrgan Ltd., China
2.200000
 0.08
Beijing Advanced Innovation Center for Structural Biology (ICSB-BJ), China
1.450000
 0.06
State Key Laboratory of Emerging Infectious Diseases, HKU, China
1.200000
 0.05
Peking University Third Hospital (PUTH), PKUHSC, China
1.000000
 0.04
National Clinical Research Center for Infectious Diseases at Shenzhen Third People's Hospital, SUSTech, China
1.000000
 0.04
The University of Hong Kong (HKU), China
0.750000
 0.03
Oncode Institute, Netherlands
0.500000
 0.02
Roche, Switzerland
0.500000
 0.02
Interested in Medical Biotechnology?